These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 9327702)
21. Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine. Gerson MC; Craft LL; McGuire N; Suresh DP; Abraham WT; Wagoner LE J Nucl Cardiol; 2002; 9(6):608-15. PubMed ID: 12466785 [TBL] [Abstract][Full Text] [Related]
22. Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study. Yamada T; Shimonagata T; Fukunami M; Kumagai K; Ogita H; Hirata A; Asai M; Makino N; Kioka H; Kusuoka H; Hori M; Hoki N J Am Coll Cardiol; 2003 Jan; 41(2):231-8. PubMed ID: 12535815 [TBL] [Abstract][Full Text] [Related]
23. The clinical value of cardiac sympathetic imaging in heart failure. Christensen TE; Kjaer A; Hasbak P Clin Physiol Funct Imaging; 2014 May; 34(3):178-82. PubMed ID: 24138454 [TBL] [Abstract][Full Text] [Related]
24. Iodine-123-metaiodobenzylguanidine scintigraphy in risk stratification of sudden death in heart failure. Martins da Silva MI; Vidigal Ferreira MJ; Morão Moreira AP Rev Port Cardiol; 2013 Jun; 32(6):509-16. PubMed ID: 23731734 [TBL] [Abstract][Full Text] [Related]
25. QT interval variability in type 2 diabetic patients with cardiac sympathetic dysinnervation assessed by 123I-metaiodobenzylguanidine scintigraphy. Sacre JW; Franjic B; Coombes JS; Marwick TH; Baumert M J Cardiovasc Electrophysiol; 2013 Mar; 24(3):305-13. PubMed ID: 23210722 [TBL] [Abstract][Full Text] [Related]
26. Cardiac 123I-MIBG reflects left ventricular functional reserve in patients with nonobstructive hypertrophic cardiomyopathy. Isobe S; Izawa H; Iwase M; Nanasato M; Nonokawa M; Ando A; Ohshima S; Nagata K; Kato K; Nishizawa T; Murohara T; Yokota M J Nucl Med; 2005 Jun; 46(6):909-16. PubMed ID: 15937299 [TBL] [Abstract][Full Text] [Related]
27. Cardiac sympathetic denervation and ongoing myocardial damage for prognosis in early stages of heart failure. Arimoto T; Takeishi Y; Niizeki T; Nozaki N; Hirono O; Watanabe T; Nitobe J; Tsunoda Y; Suzuki S; Koyama Y; Kitahara T; Okada A; Takahashi K; Kubota I J Card Fail; 2007 Feb; 13(1):34-41. PubMed ID: 17339001 [TBL] [Abstract][Full Text] [Related]
28. Impact of an exercise training program on cardiac neuronal function in heart failure patients on optimal medical therapy : A randomized Iodine-123 metaiodobenzylguanidine scintigraphy study. Valborgland T; Isaksen K; Munk PS; Grabowski ZP; Larsen AI J Nucl Cardiol; 2018 Aug; 25(4):1164-1171. PubMed ID: 28097476 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of sympathetic re-innervation in heterotopic cardiac transplants by iodine-123-metaiodobenzylguanidine (I-123-MIBG) imaging. Yap KS; Gould P; Kalff V; Kaye DM; Esmore D; Kelly MJ J Heart Lung Transplant; 2006 Aug; 25(8):977-80. PubMed ID: 16890120 [TBL] [Abstract][Full Text] [Related]
30. Statin therapy and cardiac sympathetic activity in patients with heart failure: a 123iodine-metaiodobenzylguanidine myocardial scintigraphy study. Fernandes IA; Vianna LC; Freitas RA; Miranda SM; Mesquita ET; Mesquita CT; da Nóbrega AC Int J Cardiol; 2014 Oct; 176(3):1181-3. PubMed ID: 25156842 [No Abstract] [Full Text] [Related]
31. Increased cardiac sympathetic activity in patients with hypothyroidism as determined by iodine-123 metaiodobenzylguanidine scintigraphy. Momose M; Inaba S; Emori T; Imamura K; Kawano K; Ueda T; Kobayashi H; Hosoda S Eur J Nucl Med; 1997 Sep; 24(9):1132-7. PubMed ID: 9283106 [TBL] [Abstract][Full Text] [Related]